Patent · US Active

Fibrin composition comprising carrier material, method and wound articles

US11827754B2 · kind B2 · utility

0Cited by
58References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2017
Grant dateNov 28, 2023
Priority date
Expiry dateJul 11, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08J2439/04
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Provided is a method of forming a fibrin hydrogel composition, the method including providing a fibrin hydrogel or precursor thereof, comprising fibrin hydrogel forming salt. The fibrin hydrogel forming salt concentration is greater than or equal to the threshold concentration to form a fibrin hydrogel. The method further includes combining the fibrin hydrogel with a carrier material. The concentration of the carrier material typically ranges from 0.1 to about 50 wt.-%. The method further includes reducing the salt concentration below the threshold concentration to form a fibrin hydrogel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.